Bard to Present at J.P. Morgan Healthcare Conference

Business Wirevia The Motley Fool
Updated

Bard to Present at J.P. Morgan Healthcare Conference

MURRAY HILL, N.J.--(BUSINESS WIRE)-- C. R. Bard, Inc. (NYS: BCR) today announced that it will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 8, 2013. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 4:30 PM Pacific Standard Time (7:30 PM Eastern Standard Time).

A live audio webcast of Bard's presentation and question and answer session will be accessible to all investors through Bard's website at http://investorrelations.crbard.com. The webcast will also be available on the website for future on-demand replay.


The recommended browser is Internet Explorer 7+. Users also should have the most recent version of Windows Media Player™, which can be downloaded at: http://microsoft.com/windows/windowsmedia/en/download/. Users may experience varying levels of performance based on their connection speed, system capabilities and the presence of a system firewall.

C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

anImage
anImage



C. R. Bard, Inc.
Investor Relations:
Todd W. Garner, 908-277-8065
Vice President, Investor Relations
or
Media Relations:
Scott T. Lowry, 908-277-8365
Vice President and Treasurer

KEYWORDS: United States North America California New Jersey

INDUSTRY KEYWORDS:

The article Bard to Present at J.P. Morgan Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement